Gut Inflammation Capsules – 2mg
2mg Capsules (BPC-157 / TB-500 / KPV / Larazotide)
Each capsule delivers a balanced 2mg blend containing BPC-157 (500mcg), TB-500 (500mcg), KPV (500mcg), and Larazotide (500mcg). This combination is designed for research use, offering a unique multi-peptide profile for advanced study applications.
$300.00 / month
Gut Inflammation Capsules combine four separately characterized research peptides — BPC-157, TB-500, KPV, and Larazotide — supplied by Advanced Peptide Institute at 99% purity for laboratory research use only. This 2mg-per-capsule formulation (500mcg of each peptide) is intended exclusively for qualified researchers studying intestinal-barrier and mucosal-signaling pathways.
What is Gut Inflammation Capsules?
This formulation combines four distinct research peptides studied within intestinal and mucosal-signaling research. BPC-157 is a pentadecapeptide fragment studied for its interaction with growth-factor and angiogenesis-related signaling pathways. TB-500, a synthetic fragment of Thymosin Beta-4, is studied for its interaction with actin-binding and cytoskeletal-regulation pathways relevant to cell-migration signaling. KPV is a tripeptide fragment derived from alpha-melanocyte-stimulating hormone, studied for its interaction with melanocortin-receptor signaling pathways. Larazotide is an octapeptide studied for its interaction with intestinal tight-junction regulation, particularly pathways associated with the zonulin signaling system. Advanced Peptide Institute combines these four peptides into a single research formulation for laboratories studying the intersection of these pathway families.
Research Applications
Gut Inflammation Capsules are studied within laboratory research examining intestinal-barrier signaling, mucosal-tissue research models, and tight-junction regulation pathways. Researchers studying zonulin-pathway signaling reference Larazotide’s tight-junction mechanism when designing intestinal-permeability assay models. Melanocortin-receptor research examining KPV’s receptor-level activity is frequently paired with cytoskeletal-regulation research referencing TB-500’s actin-binding mechanism, and growth-factor-signaling research referencing BPC-157’s angiogenesis-related pathway activity. Laboratories studying the combined interaction of these four pathway families — tight-junction regulation, melanocortin signaling, cytoskeletal regulation, and growth-factor signaling — use this formulation as a single-source multi-peptide research tool, always within in vitro or non-human in vivo laboratory models, often alongside single-peptide comparison groups.
Purity & Third-Party Testing
Advanced Peptide Institute Gut Inflammation Capsules are supplied at 99% purity, independently verified through third-party High-Performance Liquid Chromatography (HPLC) testing and mass spectrometry analysis. This dual-verification process confirms both compound identity and exact purity level prior to release for research use. A Certificate of Analysis (COA) is available for every batch at https://advancedpeptideinstitute.com/certificate-of-analysis/, allowing researchers to confirm the specifications of the exact batch received.
Storage & Handling
Store Gut Inflammation Capsules in a cool, dry place away from direct sunlight, heat, and moisture to preserve compound stability. Keep the container tightly sealed between uses and out of reach of children. Handle capsules in accordance with standard laboratory safety protocols and institutional research-handling guidelines.
Frequently Asked Questions
What purity is Advanced Peptide Institute Gut Inflammation Capsules?
Advanced Peptide Institute Gut Inflammation Capsules is supplied at 99% purity, verified by independent third-party HPLC testing and mass spectrometry. A Certificate of Analysis is available for every batch at https://advancedpeptideinstitute.com/certificate-of-analysis/.
How should Gut Inflammation Capsules be stored?
Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.
What compounds are in Gut Inflammation Capsules?
Gut Inflammation Capsules combine BPC-157, TB-500, KPV, and Larazotide, four research peptides studied for their interaction with intestinal-barrier and mucosal-signaling pathways.
Published laboratory research on BPC-157 is indexed on PubMed.
Related Research Compounds: Limitless Capsules • BPC-157 Capsules – 500mcg • Browse all Capsules research compounds • Certificate of Analysis
For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.